Zacks Investment Research Lowers National Health Investors (NHI) to Hold

Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a buy rating to a hold rating in a research note issued to investors on Friday.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other equities analysts have also commented on the company. Wells Fargo & Co reissued a hold rating on shares of National Health Investors in a research note on Tuesday, August 28th. Cantor Fitzgerald increased their price target on National Health Investors from $75.00 to $80.00 and gave the company a neutral rating in a research note on Wednesday, August 8th. SunTrust Banks reissued a hold rating and set a $79.00 price target on shares of National Health Investors in a research note on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 price target on National Health Investors and gave the company a buy rating in a research note on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $75.22.

Shares of NYSE:NHI traded down $0.10 during trading on Friday, hitting $75.98. 375,162 shares of the company’s stock were exchanged, compared to its average volume of 214,432. The company has a current ratio of 14.53, a quick ratio of 15.56 and a debt-to-equity ratio of 0.89. National Health Investors has a 52-week low of $62.71 and a 52-week high of $81.60. The stock has a market capitalization of $3.18 billion, a P/E ratio of 14.26, a P/E/G ratio of 3.23 and a beta of 0.30.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.39 by ($0.42). National Health Investors had a return on equity of 11.56% and a net margin of 53.15%. The business had revenue of $74.92 million for the quarter, compared to analysts’ expectations of $73.72 million. During the same quarter in the prior year, the business posted $1.37 EPS. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, research analysts predict that National Health Investors will post 5.5 earnings per share for the current fiscal year.

Institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in National Health Investors by 35.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,926 shares of the real estate investment trust’s stock valued at $1,173,000 after buying an additional 4,144 shares during the last quarter. First Trust Advisors LP lifted its stake in shares of National Health Investors by 26.2% in the 2nd quarter. First Trust Advisors LP now owns 82,106 shares of the real estate investment trust’s stock valued at $6,050,000 after purchasing an additional 17,059 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of National Health Investors by 7.6% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 42,521 shares of the real estate investment trust’s stock valued at $3,133,000 after purchasing an additional 2,987 shares during the last quarter. Macquarie Group Ltd. lifted its stake in shares of National Health Investors by 15.5% in the 2nd quarter. Macquarie Group Ltd. now owns 13,400 shares of the real estate investment trust’s stock valued at $987,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Paloma Partners Management Co bought a new stake in shares of National Health Investors in the 2nd quarter valued at approximately $566,000. 68.79% of the stock is owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: Cost of Capital

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply